Annual report 2017

Worldwide Phase 3 program in IPF announced

Next steps with GLPG1690 in IPF

Read our press release

Welcome to Galapagos

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives. 

Learn more about Galapagos

News

Loading...

All Galapagos news

Events

Loading...

All Galapagos events

Current Openings

Loading...

All Current Openings